[Quantitative assay of growth response of clinical breast cancer cells against E2 or E2-conjugated drugs].
Matsuoka
H
H
Clinical Research Institute, National Kyushu Cancer Center.
Furusawa
M
M
Sugimachi
K
K
D000970:Antineoplastic Agents / Q000494:pharmacology; D001943:Breast Neoplasms / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects*; D002699:Chlorambucil / Q000031:analogs & derivatives / Q000494:pharmacology; D004354:Drug Screening Assays, Antitumor; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology*; D004961:Estramustine / Q000494:pharmacology; D006801:Humans; D011960:Receptors, Estrogen / Q000032:analysis; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D011960:Receptors, Estrogen; D002699:Chlorambucil; D004961:Estramustine; D004958:Estradiol; C036613:bestrabucil